It is, however, frequently epigenetically silenced, which has been demonstrated, for example, by restoring SMARCA2 function in SMARCA2-deficient cancers using histone deacetylase (HDAC) inhibitors [41]. The gene discussed is SMARCA2; the disease is cancer.